메뉴 건너뛰기




Volumn 47, Issue 2, 2009, Pages 322-326

Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; ISOENZYME; MEROPENEM; BACTERIAL PROTEIN; BETA LACTAMASE;

EID: 60849111684     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01550-08     Document Type: Article
Times cited : (75)

References (30)
  • 1
    • 27644491909 scopus 로고    scopus 로고
    • Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase
    • Alba, J., Y. Ishii, K. Thomson, E. S. Moland, and K. Yamaguchi. 2005. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. Antimicrob. Agents Chemother. 49:4760-4762.
    • (2005) Antimicrob. Agents Chemother , vol.49 , pp. 4760-4762
    • Alba, J.1    Ishii, Y.2    Thomson, K.3    Moland, E.S.4    Yamaguchi, K.5
  • 3
    • 0031026934 scopus 로고    scopus 로고
    • Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
    • Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
    • (1997) Antimicrob. Agents Chemother , vol.41 , pp. 563-569
    • Bradford, P.A.1    Urban, C.2    Mariano, N.3    Projan, S.J.4    Rahal, J.J.5    Bush, K.6
  • 4
    • 33947357813 scopus 로고    scopus 로고
    • Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York
    • Bratu, S., S. Brooks, S. Burney, S. Kochar, J. Gupta, D. Landman, and J. Quale. 2007. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975.
    • (2007) Clin. Infect. Dis , vol.44 , pp. 972-975
    • Bratu, S.1    Brooks, S.2    Burney, S.3    Kochar, S.4    Gupta, J.5    Landman, D.6    Quale, J.7
  • 5
    • 22144436291 scopus 로고    scopus 로고
    • Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium
    • Bratu, S., D. Landman, R. Haag, R. Recco, A. Eramo, M. Alam, and J. Quale. 2005. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch. Intern. Med. 165:1430-1435.
    • (2005) Arch. Intern. Med , vol.165 , pp. 1430-1435
    • Bratu, S.1    Landman, D.2    Haag, R.3    Recco, R.4    Eramo, A.5    Alam, M.6    Quale, J.7
  • 7
    • 38649120083 scopus 로고    scopus 로고
    • Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece
    • Cuzon, G., T. Naas, M. C. Demachy, and P. Nordmann. 2008. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob. Agents Chemother. 52:796-797.
    • (2008) Antimicrob. Agents Chemother , vol.52 , pp. 796-797
    • Cuzon, G.1    Naas, T.2    Demachy, M.C.3    Nordmann, P.4
  • 8
    • 33845210947 scopus 로고    scopus 로고
    • Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000-2004)
    • Deshpande, L. M., R. N. Jones, T. R. Fritsche, and H. S. Sader. 2006. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb. Drug Resist. 12:223-230.
    • (2006) Microb. Drug Resist , vol.12 , pp. 223-230
    • Deshpande, L.M.1    Jones, R.N.2    Fritsche, T.R.3    Sader, H.S.4
  • 9
    • 33845223883 scopus 로고    scopus 로고
    • Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999-2005)
    • Deshpande, L. M., P. R. Rhomberg, H. S. Sader, and R. N. Jones. 2006. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn. Microbiol. Infect. Dis. 56:367-372.
    • (2006) Diagn. Microbiol. Infect. Dis , vol.56 , pp. 367-372
    • Deshpande, L.M.1    Rhomberg, P.R.2    Sader, H.S.3    Jones, R.N.4
  • 12
    • 0033584053 scopus 로고    scopus 로고
    • Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore
    • Koh, T. H., G. S. Babini, N. Woodford, L. H. Sng, L. M. Hall, and D. M. Livermore. 1999. Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353:2162.
    • (1999) Lancet , vol.353 , pp. 2162
    • Koh, T.H.1    Babini, G.S.2    Woodford, N.3    Sng, L.H.4    Hall, L.M.5    Livermore, D.M.6
  • 13
    • 34547642726 scopus 로고    scopus 로고
    • Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital
    • Leavitt, A., S. Navon-Venezia, I. Chmelnitsky, M. J. Schwaber, and Y. Carmeli. 2007. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob. Agents Chemother. 51:3026-3029.
    • (2007) Antimicrob. Agents Chemother , vol.51 , pp. 3026-3029
    • Leavitt, A.1    Navon-Venezia, S.2    Chmelnitsky, I.3    Schwaber, M.J.4    Carmeli, Y.5
  • 14
    • 0035262126 scopus 로고    scopus 로고
    • Modified Hodge and EDTA-disk synergy tests to screen metallo-beta- lactamase-producing strains of Pseudomonas and Acinetobacter species
    • Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Yong, and J. H. Yum. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta- lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7:88-91.
    • (2001) Clin. Microbiol. Infect , vol.7 , pp. 88-91
    • Lee, K.1    Chong, Y.2    Shin, H.B.3    Kim, Y.A.4    Yong, D.5    Yum, J.H.6
  • 16
    • 25844520534 scopus 로고    scopus 로고
    • Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France
    • Naas, T., P. Nordmann, G. Vedel, and C. Poyart. 2005. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob. Agents Chemother. 49:4423-4424.
    • (2005) Antimicrob. Agents Chemother , vol.49 , pp. 4423-4424
    • Naas, T.1    Nordmann, P.2    Vedel, G.3    Poyart, C.4
  • 17
    • 33748698691 scopus 로고    scopus 로고
    • Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel
    • Navon-Venezia, S., I. Chmelnitsky, A. Leavitt, M. J. Schwaber, D. Schwartz, and Y. Carmeli. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101.
    • (2006) Antimicrob. Agents Chemother , vol.50 , pp. 3098-3101
    • Navon-Venezia, S.1    Chmelnitsky, I.2    Leavitt, A.3    Schwaber, M.J.4    Schwartz, D.5    Carmeli, Y.6
  • 19
    • 0347951399 scopus 로고    scopus 로고
    • Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae
    • Poirel, L., C. Heritier, V. Tolun, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.
    • (2004) Antimicrob. Agents Chemother , vol.48 , pp. 15-22
    • Poirel, L.1    Heritier, C.2    Tolun, V.3    Nordmann, P.4
  • 21
    • 0037339196 scopus 로고    scopus 로고
    • Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.
    • Smith Moland, E., N. D. Hanson, V. L. Herrera, J. A. Black, T. J. Lockhart, A. Hossain, J. A. Johnson, R. V. Goering, and K. S. Thomson. 2003. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother. 51:711-714.
  • 22
    • 34247178075 scopus 로고    scopus 로고
    • Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, J. P. Quinn, and the Colombian Nosocomial Resistance Study Group. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553-1555.
    • Villegas, M. V., K. Lolans, A. Correa, J. N. Kattan, J. A. Lopez, J. P. Quinn, and the Colombian Nosocomial Resistance Study Group. 2007. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother. 51:1553-1555.
  • 23
    • 33746933470 scopus 로고    scopus 로고
    • Villegas, M. V., K. Lolans, A. Correa, C. J. Suarez, J. A. Lopez, M. Vallejo, J. P. Quinn, and the Colombian Nosocomial Resistance Study Group. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.
    • Villegas, M. V., K. Lolans, A. Correa, C. J. Suarez, J. A. Lopez, M. Vallejo, J. P. Quinn, and the Colombian Nosocomial Resistance Study Group. 2006. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob. Agents Chemother. 50:2880-2882.
  • 30
    • 10744230588 scopus 로고    scopus 로고
    • Zanetti, G., F. Bally, G. Greub, J. Garbino, T. Kinge, D. Lew, J. A. Romand, J. Bille, D. Aymon, L. Stratchounski, L. Krawczyk, E. Rubinstein, M. D. Schaller, R. Chiolero, M. P. Glauser, A. Cometta, and the Cefepime Study Group. 2003. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob. Agents Chemother. 47:3442-3447.
    • Zanetti, G., F. Bally, G. Greub, J. Garbino, T. Kinge, D. Lew, J. A. Romand, J. Bille, D. Aymon, L. Stratchounski, L. Krawczyk, E. Rubinstein, M. D. Schaller, R. Chiolero, M. P. Glauser, A. Cometta, and the Cefepime Study Group. 2003. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob. Agents Chemother. 47:3442-3447.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.